C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2011
11/10/2011	WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	WO2011139765A2 Compounds that modulate intracellular calcium
11/10/2011	WO2011138265A2 Indole and indazole derivatives as orexin receptor antagonists
11/10/2011	US20110275813 Bicylic 1,3-diones and Their Use as Insecticides, Acaricides and/or Fungicides
11/10/2011	US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	CA2798082A1 Desazadesferrothiocin analogues as metal chelation agents
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP1007513B1 Pesticidal 1-aryl-3-iminopyrazoles
11/09/2011	CN102239150A Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
11/09/2011	CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof
11/09/2011	CN101870678B Pyrazole compound and preparation method thereof
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101253155B 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
11/08/2011	US8053572 Alkyl-analide producing method
11/08/2011	US8053459 Selenolopyrazole derivatives and use thereof as anticancer agents
11/08/2011	US8053458 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example
11/08/2011	US8053453 Pyrazolone compounds and thrombopoietin receptor activator
11/08/2011	US8053439 Benzophenone derivatives useful for inhibiting formation of microtubule
11/08/2011	US8053431 Pharmaceutical use of substituted amides
11/08/2011	US8052995 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	US8052994 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	US8052993 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	CA2405408C Pyrazole compounds
11/03/2011	WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011	WO2011136318A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	US20110269971 Process for production of hydroxyadamantaneamine
11/03/2011	US20110269808 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	CA2793859A1 Therapeutic agent and preventative agent for alzheimer's disease
11/02/2011	EP2383258A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
11/02/2011	EP2382189A1 Toluidine sulfonamides and their use
11/02/2011	EP2381775A1 Small molecule inhibitors of necroptosis
11/02/2011	EP2197841B1 Guanidine-containing compounds useful as muscarinic receptor antagonists
11/02/2011	CN102229546A 1,4-pentadiene-3-ketone compound including sulfonic acid ester group, preparation method and use thereof
11/02/2011	CN101759644B Crystalline form III of Lonidamine and preparation method thereof and composition containing same
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048897 Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
11/01/2011	US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011	CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
10/2011
10/27/2011	WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011131615A1 Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbonyl chlorides and fluorides
10/27/2011	WO2011131546A1 Process for the preparation of pyrazole carboxylic acid amides
10/27/2011	WO2011131545A1 Process for the preparation of pyrazole carboxylic acid amides
10/27/2011	WO2011131544A1 Process for the preparation of pyrazole carboxylic acid amides
10/27/2011	WO2011131543A1 Process for the preparation of pyrazole carboxylic acid amides
10/27/2011	US20110263869 Methods for the preparation of aryl amides
10/27/2011	US20110263849 Method for rapidly methylating heteroaromatic arene and method for producing tracer for use in pet
10/27/2011	US20110263662 1,2-diamido-ethylene derivatives as orexin antagonists
10/27/2011	US20110263626 Novel bradykinin b1-antagonists
10/27/2011	US20110263562 Bicyclic compound
10/26/2011	EP2380885A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380879A1 Tetrahydroindolone and tetrahydroindazolone derivatives
10/26/2011	EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011	EP2379507A1 Sulfonamide compounds for the treatment of respiratory disorders
10/26/2011	EP2125740B1 Fungicide n-(3-phenylpropyl)carboxamide derivatives
10/26/2011	CN101386596B 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
10/25/2011	US8044083 Kinase inhibitors and methods of use thereof
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/20/2011	US20110257410 Methods for the preparation of fungicides
10/20/2011	US20110257196 Compounds for treatment of cancer
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/19/2011	EP2375896A1 Chemical process
10/19/2011	EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011	EP1761501B1 Use of n-phenylpyrazole derivatives as pesticides
10/19/2011	EP1734082B1 Monoazo/iron complex compound, charge control agent comprising the same, and toner
10/19/2011	EP1731509B1 Process for producing nitrogenous 5-membered cyclic compound
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/18/2011	US8039640 Morphine compounds for pharmaceutical compositions
10/18/2011	US8039639 Kinase inhibitors and methods of use thereof
10/18/2011	US8039502 Anti-infective agents against intracellular pathogens
10/18/2011	US8039463 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
10/13/2011	WO2011125838A1 Therapeutic agent or preventive agent for urine collection disorder
10/13/2011	WO2011125836A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	WO2011123947A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
10/13/2011	WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011062864A3 Inhibitors of nox enzymes and methods of use thereof
10/13/2011	US20110251216 Compositions and methods for inhibiting ezh2
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	CA2793730A1 Therapeutic agent or preventive agent for urine collection disorder
10/13/2011	CA2793709A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	CA2792641A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
10/12/2011	EP2374792A1 N-substituted benzene sulfonamides
10/12/2011	EP2374791A1 Insecticidal 4-phenyl-1H pyrazoles
10/12/2011	EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011	EP2373625A1 Methods for the preparation of aryl amides
10/12/2011	EP2373624A1 Transition metal complexes of a bisýthiohydrazide amide¨compound
10/12/2011	EP2257530B1 Process for preparing substituted biphenylanilides
10/12/2011	EP1695955B1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof
10/12/2011	EP1678143B8 N-substituted pyrazolyl carboxanilides
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof

1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 256